TABLE 3.
Population | Number of Studies | Number of Participants | Pooled ALT Mean* (U/L) | 95% CI | P |
---|---|---|---|---|---|
By country | < 0.001 † | ||||
0.47 ‡ | |||||
Mainland China | 26 | 138,059 | 19 | 18‐20 | |
South Korea | 20 | 157,232 | 19 | 18‐20 | |
Taiwan | 5 | 28,909 | 20 | 17‐24 | |
Japan | 4 | 4,863 | 21 | 18‐24 | |
Iran | 1 | 289 | 24 | 22‐26 | |
Israel | 1 | 228 | 20 | 19‐21 | |
India | 1 | 155 | 23 | 22‐23 | |
Malaysia | 1 | 107 | 28 | 16‐30 |
I 2 > 98% for all country analyses with more than one study, and all P values for I 2 < 0.05.
Between all available countries.
Between countries with four or more studies (Mainland China, South Korea, Taiwan, and Japan).